Cyclophosphamide versus methylprednisolone for treating neuropsychiatric involvement in systemic lupus erythematosus
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Cyclophosphamide Versus Methylprednisolone for Treating Neuropsychiatric Involvement in Systemic Lupus Erythematosus." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/440114/all/Cyclophosphamide_versus_methylprednisolone_for_treating_neuropsychiatric_involvement_in_systemic_lupus_erythematosus.
Cyclophosphamide versus methylprednisolone for treating neuropsychiatric involvement in systemic lupus erythematosus. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/440114/all/Cyclophosphamide_versus_methylprednisolone_for_treating_neuropsychiatric_involvement_in_systemic_lupus_erythematosus. Accessed March 21, 2025.
Cyclophosphamide versus methylprednisolone for treating neuropsychiatric involvement in systemic lupus erythematosus. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/440114/all/Cyclophosphamide_versus_methylprednisolone_for_treating_neuropsychiatric_involvement_in_systemic_lupus_erythematosus
Cyclophosphamide Versus Methylprednisolone for Treating Neuropsychiatric Involvement in Systemic Lupus Erythematosus [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 March 21]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/440114/all/Cyclophosphamide_versus_methylprednisolone_for_treating_neuropsychiatric_involvement_in_systemic_lupus_erythematosus.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Cyclophosphamide versus methylprednisolone for treating neuropsychiatric involvement in systemic lupus erythematosus
ID - 440114
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/440114/all/Cyclophosphamide_versus_methylprednisolone_for_treating_neuropsychiatric_involvement_in_systemic_lupus_erythematosus
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -